The FDA should not overlook unproven peptides due to their lack of proven safety and efficacy.
Claims
The FDA should not overlook unproven peptides due to their lack of proven safety and efficacy.
Parent: HealthcareEntity: FDASub-entity: Regulatory OversightImpact: negativeDate: Oct 16, 2026Target: The FDA's regulatory oversight of unproven peptides
Source posts
RFK Jr. proposes FDA look the other way on unproven peptides, report says
FDA scientists said none of the popular drugs have been proven safe or effective.
https://arstechnica.com/health/2026/10/rfk-jr-proposes-fda-look-the-other-way-on-unproven-peptides-report-says/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social
14 boosts · 12 favs · 2 replies · Oct 16, 2026
#ArsTechnica #Tech RFK Jr. proposes FDA look the other way on unproven peptides, report says https://arstechni.ca/kAvq
0 boosts · 0 favs · 0 replies · Oct 16, 2026
#arstechnica#tech